Top Patent Approvals 2010-2017

Backtest results

Metrics

1Y · since Oct 2025
Top Patent Approvals 2010-2017
Total Return+13.06%
CAGR+13.18%
Sharpe0.70
Calmar0.92
Max DD-14.32%
Volatility20.92%
Win Rate51.4%

Last year of a hypothetical backtest, Oct 30, 2025 to Oct 30, 2026. Create an account to see the full history.

About this strategy

A balanced, equal-weight portfolio of 25 major U.S. stocks, each holding 4% of the capital. It stays fixed, rebalancing only at set intervals, providing diversified exposure across technology, industrials, consumer staples and healthcare while avoiding market timing or leverage.

Current allocation

What the rules select as of Oct 30, 2026.

  • AAPL

    Apple Inc. Common Stock

    4.2%
  • AMAT

    Applied Materials, Inc. Common Stock

    4.2%
  • AVGO

    Broadcom Inc. Common Stock

    4.2%
  • BA

    Boeing Company

    4.2%
  • BKR

    Baker Hughes Company Class A Common Stock

    4.2%
  • GE

    GE Aerospace

    4.2%
  • HMC

    Honda Motor Co., Ltd. American Depositary Share, each representing three (3) shares of Common Stock

    4.2%
  • HON

    Honeywell International Inc. Common Stock

    4.2%
  • IBM

    International Business Machines Corporation

    4.2%
  • INTC

    Intel Corporation Common Stock

    4.2%
  • LPL

    LG Display Co. Ltd.

    4.2%
  • LPLA

    LPL Financial Holdings Inc. Common Stock

    4.2%
  • MDT

    Medtronic plc

    4.2%
  • MSFT

    Microsoft Corporation Common Stock

    4.2%
  • MU

    Micron Technology, Inc. Common Stock

    4.2%
  • NKE

    Nike, Inc.

    4.2%
  • ORCL

    Oracle Corp

    4.2%
  • PG

    Procter & Gamble Company

    4.2%
  • QCOM

    QUALCOMM Incorporated Common Stock

    4.2%
  • SAP

    SAP SE

    4.2%
  • SONY

    Sony Group Corporation American Depositary Shares (Each Representing One Share of Dollar Validated Common Stock)

    4.2%
  • TSM

    Taiwan Semiconductor Manufacturing Company Ltd.

    4.2%
  • TXN

    Texas Instruments Incorporated Common Stock

    4.2%
  • XRX

    Xerox Holdings Corporation Common Stock

    4.2%

Frequently asked questions

What is Top Patent Approvals 2010-2017?

A balanced, equal-weight portfolio of 25 major U.S. stocks, each holding 4% of the capital. It stays fixed, rebalancing only at set intervals, providing diversified exposure across technology, industrials, consumer staples and healthcare while avoiding market timing or leverage.

What is Top Patent Approvals 2010-2017 holding today?

As of Oct 30, 2026, Top Patent Approvals 2010-2017 allocates to AAPL 4.2%, AMAT 4.2%, AVGO 4.2%, BA 4.2%, BKR 4.2%, GE 4.2%, HMC 4.2%, HON 4.2%, IBM 4.2%, INTC 4.2%, LPL 4.2%, LPLA 4.2%, MDT 4.2%, MSFT 4.2%, MU 4.2%, NKE 4.2%, ORCL 4.2%, PG 4.2%, QCOM 4.2%, SAP 4.2%, SONY 4.2%, TSM 4.2%, TXN 4.2%, XRX 4.2%.

How has Top Patent Approvals 2010-2017 performed over the past year?

From Oct 30, 2025 to Oct 30, 2026, Top Patent Approvals 2010-2017 returned +13.9% in a hypothetical backtest. Past performance does not guarantee future results.

What is the maximum drawdown of Top Patent Approvals 2010-2017?

From Oct 30, 2025 to Oct 30, 2026, the largest peak-to-trough decline of Top Patent Approvals 2010-2017 in a hypothetical backtest was -14.3%.

How do I use Top Patent Approvals 2010-2017?

Open Top Patent Approvals 2010-2017 in Quantly to rerun the backtest, adjust the rules, and paper trade it. You can also connect a supported brokerage to trade your version live.

Backtest results are hypothetical and do not guarantee future returns. Strategies are shared by Quantly users for research only and are not investment advice.

Build your next strategy. Prove it on paper before you risk real money.

Backtest against decades of data in minutes. Connect your brokerage to paper trade, then go live when you are ready.